Related Experiment Video
Updated: Oct 17, 2025

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
7.8K
Sleep-Promotion Bundle Development, Implementation, and Evaluation in Critically Ill Adults: Roles for Pharmacists
Patricia R Louzon1, Mojdeh S Heavner2, Kyle Herod3
1AdventHealth Orlando, Orlando FL, USA.
The Annals of Pharmacotherapy
|October 6, 2021
Summary
Intensive care unit (ICU) sleep bundles improve patient sleep and reduce delirium. Pharmacists are key to developing and implementing these crucial sleep improvement strategies for critically ill adults.
Area of Science:
- Critical Care Medicine
- Sleep Medicine
- Pharmacology
Background:
- Sleep disturbances are prevalent in intensive care units (ICUs), negatively impacting patient recovery.
- Implementing structured sleep improvement bundles is a growing area of focus in critical care.
Purpose of the Study:
- To review evidence on intensive care unit (ICU) sleep improvement bundle effectiveness.
- Identify optimal sleep bundle components and implementation strategies.
- Highlight the role of pharmacists in ICU sleep bundle initiatives.
Main Methods:
- Systematic review of multiple databases (1990-2021) using keywords: sleep, intensive care, critical care, protocol, bundle.
- Screening, data extraction, and risk-of-bias assessment of identified studies.
- Review of ICU quality improvement literature and Institute for Healthcare Improvement guidance.
Main Results:
- Nine studies (3 randomized, 1 quasi-experimental, 5 before-and-after) met inclusion criteria.
- Bundles primarily used nonpharmacological interventions; few included medication strategies.
- Associated outcomes included reduced delirium (5 studies), improved total sleep time (2 studies), and improved patient-perceived sleep (2 studies).
- Pharmacists were involved in 4 studies.
Conclusions:
- Sleep improvement bundles are recommended for all critically ill adults.
- Individualize bundle components and team roles at the institutional/ICU level.
- Pharmacists can lead the development and implementation of ICU sleep bundles.
More Related Videos
Related Concept Videos
Management of Insomnia
341
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
341
Sedatives and Hypnotics Drugs: Miscellaneous Agents
281
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
281
Sedatives and Hypnotics: Overview
817
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
817
Drug Dosing: Geriatric Patients
30
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
30
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
160
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
160
Pharmacodynamics in Geriatric Patients: Effects of Age
42
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
42

